Participants
![Prof. José Luis Zamorano](/images/2020/03/20/jose-luis-zamorano__374x374.png)
Prof. José Luis ZamoranoHospital Universitario Ramón y Cajal, Madrid (Spain)
Residual cardiovascular risk. We can do more!
![Prof. Alberto Zambon](/images/2022/03/15/alberto-zambon.jpg)
Prof. Alberto Zambon Università di Padova (Italy)
Residual CV risk: what is this? Role of lipids and inflammation and how to identify the patient
![Prof. John Chapman](/images/2022/05/04/chapman.jpg)
Prof. John Chapman Hôpital Pitie-Salpêtrière, Paris (France)
Icosapent ethyl MoA: what do we know?
![Prof. Xavier Garcia-Moll](/images/2022/01/19/xavier-garcia-moll.jpg)
Prof. Xavier Garcia-Moll Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
Icosapent ethyl: evidence and guidelines recommendations